Reuters Health Report

If you are having trouble viewing this email or would like to view it in your web browser, CLICK HERE

Good Morning Postlinuxeg, TUE 25 May 2010 
 
FDA needs more clout to make food supply safer
Researchers try new approaches to preventing HIV
Abbott heart valve clip effective after 2 years: study
Scientists find clues to kidney transplant success
Lupin gets FDA nod for high blood pressure tablets
Fewer sugary drinks may lower blood pressure: study
Study links viral infection to juvenile diabetes
Doctor preferences may explain high C-section rates
Study finds big decrease in global child mortality
Many vaccines at once OK for kids' brains: study

FDA needs more clout to make food supply safer
May 24, 2010 07:10 PM ET
WASHINGTON (Reuters) - The Food and Drug Administration needs greater authority, more cooperation from other agencies and must do more scientific research to help make the U.S. food supply safer, the General Accountability Office said on Monday.

Full Article
Researchers try new approaches to preventing HIV
May 24, 2010 07:07 PM ET
(Reuters) - Tablets, insertable rings and dissolving films can effectively deliver drugs to help protect women and perhaps men from infection with the AIDS virus, researchers reported on Monday.

Full Article
Abbott heart valve clip effective after 2 years: study
May 25, 2010 07:30 AM ET
NEW YORK (Reuters) - An experimental minimally invasive technique developed by Abbott Laboratories to repair the most common type of heart valve problem appeared to be as durable as surgical repair two years after the procedure, according to analysis of data presented on Tuesday.

Full Article
Scientists find clues to kidney transplant success
May 24, 2010 07:03 PM ET
LONDON (Reuters) - European scientists have found a full range of markers in the blood of kidney transplant patients which could predict whether their new organ will be a success and whether they need large amounts of medication to help it.

Full Article
Lupin gets FDA nod for high blood pressure tablets
May 25, 2010 06:13 AM ET
MUMBAI (Reuters) - Pharma major Lupin Ltd has received FDA approval for its losartan potassium and hydrochlorothiazide tablets, the drug regulator's website showed on Tuesday.

Full Article
Fewer sugary drinks may lower blood pressure: study
May 24, 2010 04:02 PM ET
CHICAGO (Reuters) - Drinking fewer sugary drinks may help lower blood pressure, U.S. researchers said on Monday in findings adding to a growing body of research supporting cutting back on sweetened beverages.

Full Article
Study links viral infection to juvenile diabetes
May 24, 2010 04:01 PM ET
LONDON (Reuters) - Italian scientists have found a significant link between juvenile diabetes and a common virus that usually only causes a mild infection -- a discovery that may give clues as to what triggers the disease.

Full Article
Doctor preferences may explain high C-section rates
May 24, 2010 05:30 PM ET
NEW YORK (Reuters Health) - The number of Cesarean sections performed at hospitals across British Columbia is highly variable, Canadian researchers have found.

Full Article
Study finds big decrease in global child mortality
May 24, 2010 11:20 AM ET
WASHINGTON (Reuters) - Fewer children are dying around the world, with deaths among children under 5 falling in almost every country, U.S. researchers reported on Sunday.

Full Article
Many vaccines at once OK for kids' brains: study
May 24, 2010 11:32 AM ET
NEW YORK (Reuters Health) - Parents can rest assured that getting kids their vaccine shots on time will not hurt their mental skills later on, doctors said on Monday.

Full Article
 
 











REUTERS www.reuters.com
Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book.Details
Subscribe to other Reuters newsletters
Unsubscribe from this newsletter.


Forward to a friend Send this mailing to a friend or colleague


Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS RSS Feed | Interactive TV | Labs | Reuters in Second Life | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

0 comentários: